SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-027813
Filing Date
2021-05-14
Accepted
2021-05-14 08:02:07
Documents
59
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pmvp-10q_20210331.htm 10-Q 1379089
2 EX-31.1 pmvp-ex311_7.htm EX-31.1 19914
3 EX-31.2 pmvp-ex312_8.htm EX-31.2 20471
4 EX-32.1 pmvp-ex321_9.htm EX-32.1 9621
5 EX-32.2 pmvp-ex322_6.htm EX-32.2 9849
  Complete submission text file 0001564590-21-027813.txt   5115815

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pmvp-20210331.xml EX-101.INS 1000134
7 XBRL TAXONOMY EXTENSION SCHEMA pmvp-20210331.xsd EX-101.SCH 40657
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pmvp-20210331_cal.xml EX-101.CAL 38367
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pmvp-20210331_def.xml EX-101.DEF 124061
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pmvp-20210331_lab.xml EX-101.LAB 337639
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pmvp-20210331_pre.xml EX-101.PRE 252142
Mailing Address 8 CLARKE DRIVE CRANBURY NJ 08512
Business Address 8 CLARKE DRIVE CRANBURY NJ 08512 (609) 642-6664
PMV Pharmaceuticals, Inc. (Filer) CIK: 0001699382 (see all company filings)

IRS No.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39539 | Film No.: 21921993
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences